指南与共识母胎医学产科

双胎贫血-红细胞增多序列征的共识诊断标准与监测:德尔菲法

Consensus diagnostic criteria and monitoring of twin anemia-polycythemia sequence: Delphi procedure.
指南 / 共识 · Ultrasound Obstet Gynecol · 2020-01-01

该研究采用德尔菲法对国际TAPS专家进行三轮咨询,33名专家完成全部三轮。共识确定产前诊断标准为贫血胎儿大脑中动脉收缩期峰值流速≥1.5 MoM且红细胞增多胎儿≤0.8 MoM,或两者差值≥1 MoM;产后标准为血红蛋白差≥8 g/dL及网织红细胞比值≥1.7。监测间隔为每2周,确诊后每周监测。

要点

  • 产前TAPS诊断:贫血胎儿MCA-PSV≥1.5 MoM且红细胞增多胎儿≤0.8 MoM,或差值≥1 MoM。
  • 产后TAPS诊断:血红蛋白差≥8 g/dL且网织红细胞比值≥1.7。
  • 监测间隔每2周,确诊后每周监测,但开始监测的孕周未达成共识。

核心结论

  • 专家小组就TAPS的诊断特征及相关参数截断值达成共识,未来需研究验证这些诊断特征后方可用于干预临床试验。

研究设计与样本

  • 德尔菲法专家共识,邀请132名国际TAPS专家,50名参与第一轮,33名(66%)完成全部三轮。

主要发现

  • 专家一致认为TAPS监测间隔应为每2周,严重程度产前应基于大脑中动脉收缩期峰值流速的分类系统评估,但开始监测的孕周未达成共识。
  • 确诊TAPS后监测应每周进行。
  • 产前诊断TAPS同意采用贫血胎儿MCA-PSV≥1.5 MoM且红细胞增多胎儿≤0.8 MoM,或MCA-PSV差值≥1 MoM。
  • 产后诊断TAPS同意采用血红蛋白差≥8 g/dL且双胎网织红细胞比值≥1.7。
  • 产前干预的MCA-PSV截断值或其差值未达成共识。

关键数值与推荐

  • 产前诊断TAPS:贫血胎儿MCA-PSV≥1.5 MoM且红细胞增多胎儿≤0.8 MoM,或MCA-PSV差值≥1 MoM。
  • 产后诊断TAPS:血红蛋白差≥8 g/dL且网织红细胞比值≥1.7。
  • 监测间隔:每2周;确诊TAPS后每周监测。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 未来需研究验证这些诊断特征后方可用于干预临床试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Twin anemia-polycythemia sequence (TAPS) is associated with increased perinatal morbidity and mortality. Inconsistencies in the diagnostic criteria for TAPS exist, which hinder the ability to establish robust evidence-based management or monitoring protocols. The main aim of this study was to determine, by expert consensus using a Delphi procedure, the key diagnostic features and optimal monitoring approach for TAPS. METHODS: A Delphi process was conducted among an international panel of experts on TAPS. Panel members were provided with a list of literature-based parameters for diagnosing and monitoring TAPS. They were asked to rate the importance of the parameters on a five-point Likert scale. Consensus was sought to determine the cut-off values for accepted parameters, as well as parameters used in the monitoring of and assessment of outcome in twin pregnancy complicated by TAPS. RESULTS: A total of 132 experts were approached. Fifty experts joined the first round, of whom 33 (66%) completed all three rounds. There was agreement that the monitoring interval for the development of TAPS should be every 2 weeks and that the severity should be assessed antenatally using a classification system based on middle cerebral artery (MCA) peak systolic velocity (PSV), but there was no agreement on the gestational age at which to start monitoring. Once the diagnosis of TAPS is made, monitoring should be scheduled weekly. For the antenatal diagnosis of TAPS, the combination of MCA-PSV ≥ 1.5 MoM in the anemic twin and ≤ 0.8 MoM in the polycythemic twin was agreed. Alternatively, MCA-PSV discordance ≥ 1 MoM can be used to diagnose TAPS. Postnatally, hemoglobin difference ≥ 8 g/dL and intertwin reticulocyte ratio ≥ 1.7 were agreed criteria for diagnosis of TAPS. There was no agreement on the cut-off of MCA-PSV or its discordance for prenatal intervention. The panel agreed on prioritizing perinatal and long-term survival outcomes in follow-up studies. CONCLUSIONS: Consensus-based diagnostic features of TAPS, as well as cut-off values for the parameters involved, were agreed upon by a panel of experts. Future studies are needed to validate these diagnostic features before they can be used in clinical trials of interventions. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Khalil A, Gordijn S, Ganzevoort W, et al. Consensus diagnostic criteria and monitoring of twin anemia-polycythemia sequence: Delphi procedure. Ultrasound Obstet Gynecol. 2020. PMID: 31605505. doi:10.1002/uog.21882

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。